A new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinoma

Hempel, L.L.HempelLapa, C.C.LapaDierks, A.A.DierksVeloso de Oliveira, J.J.Veloso de OliveiraPhilipp, PatrickPatrickPhilippOyarzun Laura, C.C.Oyarzun LauraWersag, S.S.WersagRobert, S.S.RobertHempel, D.D.Hempel2022-09-062022-09-062022https://publica.fraunhofer.de/handle/publica/42517610.1055/s-0042-1755749enA new promising oncogenic target (p.C382R) for treatment with pemigatinib in patients with cholangiocarcinomajournal article